Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile

Background: Most of the studies of HIV-1 infection in South America have been limited to Brazil and little is known about the viral variants that are causing disease elsewhere in the continent. Aim: To determine the characteristics of the viral variants present in Chile as well as patterns of viral...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pérez C,Carlos, Vial C,Pablo, Dorman,Karin S, Wang,Greg, Wang,Guangqiang, Abarca V,Katia, Sinsheimer,Janet S, Kaplan,Andrew H
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 1999
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98871999001100002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98871999001100002
record_format dspace
spelling oai:scielo:S0034-988719990011000022005-11-23Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, ChilePérez C,CarlosVial C,PabloDorman,Karin SWang,GregWang,GuangqiangAbarca V,KatiaSinsheimer,Janet SKaplan,Andrew H Acquired immunodeficiency syndrome AIDS serodiagnosis HIV-1 Virology Background: Most of the studies of HIV-1 infection in South America have been limited to Brazil and little is known about the viral variants that are causing disease elsewhere in the continent. Aim: To determine the characteristics of the viral variants present in Chile as well as patterns of viral transmission. Material and methods: Viral sequences were obtained from 21 HIV-1 infected people from Santiago, Chile who were infected either via sexual contact or intravenous drug use. Cloned sequences obtained from both the third variable and conserved regions of the envelope as well as the viral protease were evaluated. Results: We found only clade B subtype viruses in Santiago. An evaluation of the envelope gene revealed no evidence that the sequences were monophyletic by risk group. A number of the protease sequences were predicted to encode amino acid substitutions commonly found during selection for protease inhibitor resistance. Conclusions: The HIV-1 strains studied in Chile, belong to the subtype B. There is no molecular evidence of separate introductions of the virus into the different risk groups. A number of substitutions in the protease gene that may confer resistance to protease inhibitors were found in patients with no previous exposure to this class of drugs.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.127 n.11 19991999-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98871999001100002es10.4067/S0034-98871999001100002
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Acquired immunodeficiency syndrome
AIDS serodiagnosis
HIV-1
Virology
spellingShingle Acquired immunodeficiency syndrome
AIDS serodiagnosis
HIV-1
Virology
Pérez C,Carlos
Vial C,Pablo
Dorman,Karin S
Wang,Greg
Wang,Guangqiang
Abarca V,Katia
Sinsheimer,Janet S
Kaplan,Andrew H
Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile
description Background: Most of the studies of HIV-1 infection in South America have been limited to Brazil and little is known about the viral variants that are causing disease elsewhere in the continent. Aim: To determine the characteristics of the viral variants present in Chile as well as patterns of viral transmission. Material and methods: Viral sequences were obtained from 21 HIV-1 infected people from Santiago, Chile who were infected either via sexual contact or intravenous drug use. Cloned sequences obtained from both the third variable and conserved regions of the envelope as well as the viral protease were evaluated. Results: We found only clade B subtype viruses in Santiago. An evaluation of the envelope gene revealed no evidence that the sequences were monophyletic by risk group. A number of the protease sequences were predicted to encode amino acid substitutions commonly found during selection for protease inhibitor resistance. Conclusions: The HIV-1 strains studied in Chile, belong to the subtype B. There is no molecular evidence of separate introductions of the virus into the different risk groups. A number of substitutions in the protease gene that may confer resistance to protease inhibitors were found in patients with no previous exposure to this class of drugs.
author Pérez C,Carlos
Vial C,Pablo
Dorman,Karin S
Wang,Greg
Wang,Guangqiang
Abarca V,Katia
Sinsheimer,Janet S
Kaplan,Andrew H
author_facet Pérez C,Carlos
Vial C,Pablo
Dorman,Karin S
Wang,Greg
Wang,Guangqiang
Abarca V,Katia
Sinsheimer,Janet S
Kaplan,Andrew H
author_sort Pérez C,Carlos
title Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile
title_short Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile
title_full Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile
title_fullStr Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile
title_full_unstemmed Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile
title_sort epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en santiago, chile
publisher Sociedad Médica de Santiago
publishDate 1999
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98871999001100002
work_keys_str_mv AT perezccarlos epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
AT vialcpablo epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
AT dormankarins epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
AT wanggreg epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
AT wangguangqiang epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
AT abarcavkatia epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
AT sinsheimerjanets epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
AT kaplanandrewh epidemiologiamoleculardelvirusdeinmunodeficienciahumanatipo1ensantiagochile
_version_ 1718435888422191104